BioVie Holds Annual Shareholder Meeting

• BioVie shareholders approved an expansion of the 2019 Omnibus Equity Incentive Plan at the November 10, 2026, annual meeting.
• The approved amendment increases Class A common shares available for issuance under the plan from 399,509 to 3,100,000.
• Shareholders elected all six director nominees.
• EisnerAmper LLP’s appointment as independent auditor was ratified for the fiscal year ending June 30, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001520138-26-000471), on November 10, 2026, and is solely responsible for the information contained therein.